Cost-Effectiveness of Herpes Zoster Vaccine: Flawed Assumptions Regarding Efficacy against Postherpetic Neuralgia
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 1, 2007
has subject area
- 06 Biological Sciences (FoR)
- 11 Medical and Health Sciences (FoR)
- Adult (MeSH)
- Aged (MeSH)
- Anti-HIV Agents (MeSH)
- Antiretroviral Therapy, Highly Active (MeSH)
- Cohort Studies (MeSH)
- Cost-Benefit Analysis (MeSH)
- Delivery of Health Care (MeSH)
- Female (MeSH)
- HIV Infections (MeSH)
- Herpes Zoster (MeSH)
- Herpes Zoster Vaccine (MeSH)
- Humans (MeSH)
- Male (MeSH)
- Microbiology (Science Metrix)
- Neuralgia, Postherpetic (MeSH)
- Patient Compliance (MeSH)
- Socioeconomic Factors (MeSH)
published in
- Clinical Infectious Diseases Journal